Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Strong Predictors of Chromosomal Aberrations and Myeloid Neoplasia Following Immunosuppression Therapy for Severe Aplastic Anemia: A Retrospective Cohort Study

Emma M. Groarke, Bhavisha A. Patel, Ruba Shalhoub, Fernanda Gutierrez-Rodrigues, Parth Desai, Harshraj Leuva, Casey Paton, Nina Spitofsky, Jennifer Lotter, Olga Rios, Richard W. Childs, David J. Young, Alina Dulau-Florea, Cynthia E. Dunbar, Katherine R. Calvo, Colin O. Wu, Neal S. Young

Blood (2021) 138 (Supplement 1): 601.

https://doi.org/10.1182/blood-2021-146070

Published: 2021

Journal Articles

Myeloid Mixed Chimerism and Relapse in Myelofibrosis after Allogeneic Stem Cell Transplant

Samer A. Srour, MB ChB, MS, Parth Desai, MD MBBS, Stefan O. Ciurea, Qaiser Bashir, MD MBBS, Betul Oran, MDMS, Amanda L. Olson, MD, Sairah Ahmed, MD, Prithviraj Bose, MD, Rohtesh S. Mehta, MDMPH,MS, Naveen Pemmaraju, MD, Srdan Verstovsek, MD PhD, Richard E Champlin, MD, Uday Popat, MD

Blood (2017) 130 (Supplement 1): 2007.

https://doi.org/10.1182/blood.V130.Suppl_1.2007.2007

Published: 2017

Journal Articles

A Rare Case of Pearson's Syndrome with Predominant Hematological Manifestations and Novel Mitochondrial Deletion

Parth Desai, MD MBBS, Annapurna Saksena, MD MBBS, Prasad Sudhir Dange, Richa Gupta, Seema Kapoor, Tejinder Singh

Blood (2017) 130 (Supplement 1): 4958.

https://doi.org/10.1182/blood.V130.Suppl_1.4958.4958

Published: 2017

Journal Articles

Revisiting Cytochemical Myeloperoxidase (MPO) Stain for Early Diagnosis of Acute Promyelocytic Leukemia (APML) in Areas with Limited Resources: An Experience from a Tertiary Care Center in India

Annapurna Saksena, MD MBBS, Parth Desai, MD MBBS, Vishal Chauhan, MD, Naresh Gupta, MD, Tejinder Singh

Blood (2017) 130 (Supplement 1): 5096.

https://doi.org/10.1182/blood.V130.Suppl_1.5096.5096

Published: 2017

Journal Articles

MYC Copy Number Aberrancies Predict a Worse Prognosis in Patients with Diffuse Large B-Cell Lymphoma

Andres E. Quesada, MD, Parth Desai, MD, Guilin Tang, MD, Pei Lin, MD, Jason R. Westin, MD, Adam C. Seegmiller, MD PhD, C. Cameron Yin, MD PhD, Wei Wang, MD, Jie Xu, MD, Roberto N. Miranda, MD, Nishitha Reddy, MD MSCI, MBBS, L. Jeffrey Medeiros, MD, Shaoying Li, MD

Blood (2016) 128 (22): 154.

https://doi.org/10.1182/blood.V128.22.154.154

Published: 2016

Journal Articles

Patient Choice and Lack of Medicare Coverage for HCT Are the Major Reasons Why Transplant Eligible Myelofibrosis Patients Do Not Undergo Transplant

Parth Desai, MD, Julianne Chen, Diane Liu, Jimin Wu, Sairah Ahmed, MD, Betul Oran, MD, Stefan O. Ciurea, MD, Amin M. Alousi, MD, Srdan Verstovsek, MD, Richard E. Champlin, MD, Uday R. Popat, MD

Blood (2015) 126 (23): 3324.

https://doi.org/10.1182/blood.V126.23.3324.3324

Published: 2015

Journal Articles

MYC/BCL2 Double Hit Lymphoma: What Really Matters

Annapurna Saksena, MD, Parth Desai, MD, Zhuang Zuo, MD PhD, Jie Xu, MD, Pei Lin, MD, Adam C. Seegmiller, MD PhD, C. Cameron Yin, MDPhD, Guilin Tang, MD, Roberto N. Miranda, MD, Jeffrey L. Jorgensen, MD PhD, Nishitha M Reddy, M.B.B.S., L. Jeffrey Medeiros, Shaoying Li, MD

Blood (2015) 126 (23): 3909.

https://doi.org/10.1182/blood.V126.23.3909.3909

Published: 2015

NARROW

Strong Predictors of Chromosomal Aberrations and Myeloid Neoplasia Following Immunosuppression Therapy for Severe Aplastic Anemia: A Retrospective Cohort Study

Myeloid Mixed Chimerism and Relapse in Myelofibrosis after Allogeneic Stem Cell Transplant

A Rare Case of Pearson's Syndrome with Predominant Hematological Manifestations and Novel Mitochondrial Deletion

Revisiting Cytochemical Myeloperoxidase (MPO) Stain for Early Diagnosis of Acute Promyelocytic Leukemia (APML) in Areas with Limited Resources: An Experience from a Tertiary Care Center in India

MYC Copy Number Aberrancies Predict a Worse Prognosis in Patients with Diffuse Large B-Cell Lymphoma

Patient Choice and Lack of Medicare Coverage for HCT Are the Major Reasons Why Transplant Eligible Myelofibrosis Patients Do Not Undergo Transplant

MYC/BCL2 Double Hit Lymphoma: What Really Matters

Email alerts

ASH Publications

American Society of Hematology

Strong Predictors of Chromosomal Aberrations and Myeloid Neoplasia Following Immunosuppression Therapy for Severe Aplastic Anemia: A Retrospective Cohort Study

Myeloid Mixed Chimerism and Relapse in Myelofibrosis after Allogeneic Stem Cell Transplant

A Rare Case of Pearson's Syndrome with Predominant Hematological Manifestations and Novel Mitochondrial Deletion

Revisiting Cytochemical Myeloperoxidase (MPO) Stain for Early Diagnosis of Acute Promyelocytic Leukemia (APML) in Areas with Limited Resources: An Experience from a Tertiary Care Center in India

MYC Copy Number Aberrancies Predict a Worse Prognosis in Patients with Diffuse Large B-Cell Lymphoma

Patient Choice and Lack of Medicare Coverage for HCT Are the Major Reasons Why Transplant Eligible Myelofibrosis Patients Do Not Undergo Transplant

MYC/BCL2 Double Hit Lymphoma: What Really Matters

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only